Silencing of lincRNA-ROR inhibits BC cell proliferation, increases sensitivity to tamoxifen, and represses the activation of the PI3K/Akt/mTOR signaling pathway in MDA-MB-231 cell [203]. This evidence concerns the gene AKT1 and breast cancer.